(*) JP Approval Date: 2020. 01.23
(*) USA Approval Date: 2019. 12.23
(*) USA Launch Date: 2020. 06.02
>Receptor Antagonist Tablets
Company
Generic Name: Lemborexant
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2021. 10.19.
RTM
RTM Web-Site